Passage Bio, Inc. - Common Stock (PASG)

Passage Bio Inc is a biotechnology company focused on developing gene therapies for targeted genetic disorders

The company leverages its expertise in genetic medicine to create innovative treatments that address the root causes of diseases, with a particular emphasis on neurological conditions. By utilizing advanced vector technology and proprietary delivery systems, Passage Bio aims to provide transformative solutions that can improve patient outcomes and enhance the quality of life for individuals affected by these challenging health issues. The organization is committed to advancing its product pipeline through rigorous research and clinical development, seeking to bring groundbreaking therapies to market.